About: DOTA-TATE

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

DOTA-TATE (DOTATATE, DOTA-octreotate, oxodotreotide, DOTA-(Tyr3)-octreotate, and DOTA-0-Tyr3-Octreotate) is an eight amino acid long peptide, with a covalently bonded DOTA bifunctional chelator. DOTA-TATE can be reacted with the radionuclides gallium-68 (T1/2 = 68 min), lutetium-177 (T1/2 = 6.65 d) and copper-64 (T1/2 = 12.7 h) to form radiopharmaceuticals for positron emission tomography (PET) imaging or radionuclide therapy. 177Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets somatostatin receptors (SSR). In that form of application it is a form of targeted drug delivery.

thumbnail
Property Value
dbo:abstract
  • DOTA-TATE (DOTATATE, DOTA-octreotate, oxodotreotide, DOTA-(Tyr3)-octreotate, and DOTA-0-Tyr3-Octreotate) is an eight amino acid long peptide, with a covalently bonded DOTA bifunctional chelator. DOTA-TATE can be reacted with the radionuclides gallium-68 (T1/2 = 68 min), lutetium-177 (T1/2 = 6.65 d) and copper-64 (T1/2 = 12.7 h) to form radiopharmaceuticals for positron emission tomography (PET) imaging or radionuclide therapy. 177Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets somatostatin receptors (SSR). In that form of application it is a form of targeted drug delivery. (en)
  • オキソドトレオチド（oxodotreotide）（ドータオクトレオテートまたはドータテート。DOTA-octreotate、DOTA-TATE）は一部の癌（特に神経内分泌腫瘍）の診断・治療に用いられ得る治験薬である。様々な放射性同位体をキレートして使用される。 (ja)
dbo:alternativeName
  • DOTA-(Tyr3)-octreotate (en)
dbo:thumbnail
dbo:wikiPageID
  • 28766498 (xsd:integer)
dbo:wikiPageLength
  • 12934 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1119970028 (xsd:integer)
dbo:wikiPageWikiLink
dbp:imagefile
  • DOTATATE.svg (en)
dbp:othernames
  • DOTA--octreotate (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • DOTA-TATE (DOTATATE, DOTA-octreotate, oxodotreotide, DOTA-(Tyr3)-octreotate, and DOTA-0-Tyr3-Octreotate) is an eight amino acid long peptide, with a covalently bonded DOTA bifunctional chelator. DOTA-TATE can be reacted with the radionuclides gallium-68 (T1/2 = 68 min), lutetium-177 (T1/2 = 6.65 d) and copper-64 (T1/2 = 12.7 h) to form radiopharmaceuticals for positron emission tomography (PET) imaging or radionuclide therapy. 177Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets somatostatin receptors (SSR). In that form of application it is a form of targeted drug delivery. (en)
  • オキソドトレオチド（oxodotreotide）（ドータオクトレオテートまたはドータテート。DOTA-octreotate、DOTA-TATE）は一部の癌（特に神経内分泌腫瘍）の診断・治療に用いられ得る治験薬である。様々な放射性同位体をキレートして使用される。 (ja)
rdfs:label
  • DOTA-TATE (cs)
  • DOTA-TATE (en)
  • オキソドトレオチド (ja)
rdfs:seeAlso
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License